Novartis: New hope for HR+/HER2- Advanced Breast Cancer Patients
Novartis Pharma SAE (Novartis Egypt) has announced final overall survival (OS) results for the Phase III MONALEESA-2 study. The study ...
Editor-in-Chief
Mohamed Fahmy
Board Chairman
Tarek Lotfy
Tag: Novartis Pharma
A breakthrough treatment from Novartis sparks new hope for HR+/HER2- advanced breast cancer patients
Novartis Pharma S.A.E (Novartis Egypt), announced the launch of the newly approved treatment for PIK3CA-mutated HR+ve advanced Breast Cancer. The ...
ADVERTISEMENT
The Egyptian Gazette is the oldest English-language daily newspaper in the Middle East.
It was first published on January 26, 1880 and it is part of El Tahrir Printing and Publishing House.